Brenntag reunites specialties and essentials as CEO launches new strategy
Nov 12, 2026
Brenntag is merging its Specialties and Essentials divisions into a single platform to drive efficiency and growth across key verticals like Pharma and Nutrition. The company targets €450 million in structural EBITDA improvements and plans €1.5 billion in medium-term M&A spending.
2026-02-24
Toyobo posts substantial surge in profitShow all 16 updates